S Sundarlal Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 7.75 Cr
- Revenue Growth %
- Profit Growth 12.60%
- Ebitda 45.01%
- Net Worth -0.90%
- Total Assets -34.06%
About S Sundarlal Pharma
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2005PTC153178
-
Company No.
153178
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2005
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at S Sundarlal Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Sanghani
|
Director | 28-Feb-2011 | Current |
|
Vikramaditya Ambre
|
Director | 28-Feb-2011 | Current |
Financial Performance of S Sundarlal Pharma.
S Sundarlal Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.6% increase in profit. The company's net worth dipped by a decrease of 0.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S Sundarlal Pharma?
In 2021, S Sundarlal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Galaxystar Pharma Distributors Private LimitedVikramaditya Ambre is a mutual person
-
Sundarlal Pharma Distributors Private Limited
Vikramaditya Ambre is a mutual person
Charges (Loans)
₹0
₹77.50 M
Charges Breakdown by Lending Institutions
- Kotak Mahindra Bank Limited : 4.50 Cr
- Thane Bharat Sahakari Bank Limited : 3.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2014 | Kotak Mahindra Bank Limited | ₹4.50 Cr | Satisfied |
| 04 Nov 2011 | Thane Bharat Sahakari Bank Limited | ₹3.25 Cr | Satisfied |
How Many Employees Work at S Sundarlal Pharma?
Unlock and access historical data on people associated with S Sundarlal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S Sundarlal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S Sundarlal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
